Tình trạng nhiễm HIV, HBV, HCV và yếu tố liên quan ở một số nhóm nguy cơ cao tại Hà Nội, 2008 - 2010

111. Johnson, D. W., Dent, H. & Yao, Q. (2009), "Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data", Nephrol Dial. Transplant Journal, 24, pp. 1598-1603.

112. Joukar, F. & al. (2011), "Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran", Hepat. Mon. Journal, 11(3), pp. 178-181.

113. Kalichman, S. & Eaton, L. (2009), "Strategies for preventing HIV transmission." JAMA, 302, pp. 1531-1532.

114. Kallings, L. O. (2008), "The first postmodern pandemic: 25 years of HIV/AIDS", Internal Medicine Journal, 263, pp. 218-243.

115. Kao, J. H. (2011), "Molecular Epidemiology of Hepatitis B Virus",

Korean Intern. Med. Journal, Vol. 26(3), pp. 255-261.

116. Kaushik, K. S., Kapila, K. & Praharaj, A. K. (2011), "Shooting up: the interface of microbial infections and drug abuse", Medical Microbiology Journal, 60, pp. 408-422.

117. Kew, M. C. (2010), "Prevention of hepatocellular carcinoma", Annals of Hepatology Journal, Vol. 9(2), pp. 120-132.

118. Kew, M. C. (2012), "Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment", World J. Hepatol., Vol. 4(3), pp. 99-104.

Có thể bạn quan tâm!

Xem toàn bộ 156 trang tài liệu này.

119. Klimas, N., Koneru, A. O. & Fletcher, M. A. (2008), "Overview of HIV", Psychosomatic Medicine Journal, 70, pp. 523-530.

120. Koirala, S. R., Malla, R. R. & al. (2009), "Prevalence of Hepatitis B, Hepatitis C and HIV Infections among Chronic Renal Failure Patients on Hemodialysis", Post. Med. NAMS Journal, Vol. 9(2), pp. 6-13.

121. Konopnicki, D., Mocroft, A. & de Wit, S. (2005), "Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and

increased mortality in the EuroSIDA cohort", AIDS journal, 19, pp. 2117-2125.

122. Koutis, A. P. & al. (2012), "HIV-HBV Coinfection - A Global Challenge", N. Eng. J. of Med., 366(19), pp. 1749-1752.

123. Koziel, M. J. & Peter, M. G. (2007), "Viral Hepatitis in HIV Infection",

N. Engl. Med. Journal, 356, pp. 1445-54.

124. Kurbanob, F., Tanaka, Y. & Mizokami, M. (2010), "Review Article: Geographical and genetic diversity of the human hepatitis B virus ", Hepatology Research Journal, 40, pp. 14-30.

125. Lacombe, K., Massari, V. & al. (2006), "Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV", AIDS journal, 20, pp. 419-427.

126. Lan, Y. C., Elbeik, T. & al. (2008), "Molecular Epidemiology of HIV-

1 sbtypes and drug resistant strains in Taiwan", Medical Virology Journal, 80, pp. 183-191.

127. Lanini, S., Abbate, I. & Puro, V. (2010), "Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome", BMC Infect. Dis. Journal, 10(257), pp. 1-10.

128. Lau, K. A., Wang, B. & Saksena, N. K. (2007), "Emerging trends of HIV epidemiology in Asia", AIDS Rev. Journal, 9, pp. 218-29.

129. Lavanchy, D. (2009), "The global burden of hepatitis C", Liver Intern. Journal, 29(S1), pp. 74-81.

130. Lavanchy, D. (2011), "Evolving epidemiology of hepatitis C virus", Clin. Microbiol. Infect. Journal (Europ. Soci. of Clin. Microbiol. and Infect. Dis.), Vol. 17(2), pp. 107-115.

131. Lee, C. M., Hung, C. H. & Changchien, C. S. (2008), "Hepatitis C virus genotypes: Clinical relevance and therapeutic implications", Chang Gung Med. Journal, 31, pp. 16-25.

132. Lee, C. M., Hung, C. H., Lu, S. N. & al. (2006), "Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan", Intervirology Journal, 49, pp. 76-81.

133. Limburg, W. (2004), "Hepatitis C and Injecting drug use: Impact, Cost and Policy ", Scientific Monographs Journal, 7, pp. 21-36.

134. Lin, C. L. & Kao, J. H. (2011), "The clinical implications of hepatitis B virus genotype: Recent advances", Gastroenter. and Hepatol. Journal, 26 (1), pp. 123-130.

135. Lin, Y. T., Lan, Y. C. & al. (2007), "Molecular Epidemiology of HIV- 1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from Infection Drug Users in Taiwan", Infect. Dis. Journal, 195, pp. 1283-93.

136. Liu, C. J., Chen, P. J. & Chen, D. S. (2009), "Dual chronic hepatitis B virus and hepatitis C virus infection." Hepatol. Int. Journal, 3, pp. 517- 525.

137. Liu, J. Y., Lin, H. H., Liu, Y. C. & al. (2008), "Extremely High Prevalence and Genetic Diversity of Hepatitis C Virus Infection among HIV-Infected Injection Drug Users in Taiwan", Clinic. Infect. Dis., 46, pp. 1761-8.

138. Lopes, C. L. R. & al. (2009), "Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users Cetral-Western Brazil", Rev. Suade. Publica. Journal, 43(1), pp. 43-50.

139. Lu, M. & al. (2005), "Hepatitis C Virus Genotype Distribution in China: Predominance of Closely Related Subtype 1b Isolates and Existence of New Genotype 6 Variants", Med. Virol. Journal, 75, pp. 538-549.

140. Lugoboni, F., Quaglio, G. & al. (2009), "Bloodborne Viral Hepatitis Infections among Drug Users: The Role of Vaccination", Int. Environ. Res. Public Health Journal, 6, pp. 400-413.

141. Luksamijarulkul, P. & al. (2011), "Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand", Hepat. Mon. Journal, 11(4), pp. 273-277.

142. Ly, K. N., Xing, J., Klevens, R. M. & al. (2012), "The Increasing Burden of Mortality From Viral Hepatitis in the United States between 1999 and 2007", Annals of Internal Med. Journal, Vol. 156(4), pp. 271- 278.

143. Mallet, V. & al. (2011), "The impact of human immunodeficiency virus on viral hepatitis", Liver International Journal, 31(Suppl. 1), pp. 135- 139.

144. Martial, J., Morice, Y., Abel, S. & al. (2004), "Hepatitis C virus (HCV) genotypes in the Caribbean Island of Martinique: Evidence for a large radiation of HCV-2 and for a recent introdution from Europe of HCV-4", Clinical Microbiology Journal, pp. 784-791.

145. Martins, T. & al. (2011), "Epidemiology of hepatitis C virus infection",

Rev. Assoc. Med. Bras. Journal, 57 (1), pp. 105-110.

146. Mathers, B. M. & al. (2008), "Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review", Lancet Infect. Dis. journal, 372, pp. 1733-1745.

147. Mauss, S., Berg, T., Rocktroh, J. & Eds. (2012), Hepatology - A Clinical Textbook (Hepatology 2012-Third Edition), Flying Publisher, Hannover, Germany.

148. McMahon, B. J. (2009), "The Influence of Hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B", Hepatol. Int. Journal, 3, pp. 334-342.

149. Mehta, S. H., Astemborski, K., Kirk, G. D. & al. (2011), "Changes in Blood-borne Infection risk among Injection Drug Users", Infect. Dis. J., 203, pp. 587-594.

150. Miguel, E., Sarah, C. & Arts, E. (2000), "Role of Human Immunodeficiency Virus Type 1 Group O in the AIDS Pandemic", AIDS Reviews Journal, 2, pp. 190-202.

151. Mina, A. & al. (2010), "Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. " W. Gastroenterol. Journal, 16 (2), pp. 225-231.

152. Mitchell, A. E., Colvin, H. M., Beasley, R. P. & al. (2010), "Institute of Medicine Recommendations for The Prevention and Control of Hepatitis B and C", Hepatol. Journal, Vol. 51(3), pp. 729-733.

153. Monforte, A. D., Lepri, A. C., Castagna, A. & al. (2009), "Risk of Developing Spicific AIDS-Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis", Clinic. Infect. Dis. J., 49, pp. 612-22.

154. Murphy, D. G. & al. (2007), "Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5_Untranslated Region Sequences", Clin. Micro. Journal, 45(4), pp. 1102-1112.

155. Nantawat, W. M., Avihingsanon, A. & Ohata, P. J. (2012), "Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings", AIDS Research and Treatment Journal, 10(5), pp. 1-9.

156. Neaigus, A., Gyarmathy, V. A., Miller, M. & al. (2007), "Injecting and sexual risk correlates of HBV and HCV seroprevalence among drug injectors", Drug Alcohol Depend. Journal, 89(2-3), pp. 234-243.

157. Nelson, P. K., Mathers, B. M. & al. (2011), "Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: result of systematic reviews", Lancet Infect. Dis. journal, 378 (9791), pp. 571- 83.

158. Nguyen, N. H., Philip, V. T., Huy, N. T. & al. (2010), "Risk factors, genotype 6 prevalence and clinical characteristics of chronic hepatitis C in Southeast Asian Americans", Hepatol. Int. Journal, 4, pp. 523-529.

159. Operskalski, E. A. & Kovacs, A. (2011), "HIV/HCV co-infection: Pathogenesis, Clinical complications, treatment, and New therapeutic technologies", Curr. HIV/AIDS Rep. Journal, 8, pp. 12-22.

160. Otedo, A. E. O., McLigeyo, S. O. & Kayima, J. K. (2003), "Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country", S. Afr. Med. Journal, Vol. 93 (5), pp. 380-385.

161. Paintsil, E. & al. (2010), "Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users", Infect. Dis. Journal, 202(7), pp. 984-990.

162. Pandit, A. & Sinha, S. (2010), "Using genomic signatures for HIV-1 sub-typing", BMC Bioinformatics Journal, 11(suppl. 1), pp. S1-S26.

163. Pando, M. A. & al. (2006), "Epidemiology of human immunodeficiency virus, viral hepatitis (B and C), trpolema pallidum, and human T-cell lymphotropic I/II virus among men who have sex with men in Buenos Aires, Argentina", Sex. Trasm. Dis. Journal, 33(5), pp. 307-13.

164. Panessa, A. & al. (2009), "Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia", Viral Hepatitis Journal, 16, pp. 64-73.

165. Perez-Olmeda, M., Rios, P., Nunez, M. & al. (2002), "Virological characteristics of hepatitis C virus infection in HIV-infected patients

with chronic hepatitis C: Implications for treatment", AIDS journal, 16, pp. 493-5.

166. Perico, N. & al. (2009), "Hepatitis C infection and chronic renal diseases", Clin. Am. Soc. Nephrol. Journal, pp. 207-220.

167. Peters, P. J. & Marston, B. J. (2012), "Preventing Deaths in Persons with HIV/Hepatitis B virus coinfection: A call to accelerate prevention and treatment efforts", Infect. Dis. Journal, 205, pp. 166-8.

168. Ponamgi, S. P. D., Rahamathula, S., Kumar, Y. N. & al. (2009), "Prevalence of hepatitis C virus (HCV) coinfection in HIV infected individuals in south India and characterization of HCV genotypes", Indian Med. Microbiol. Journal, 27(1), pp. 12-6.

169. Pujol, F. H., Navas, M. & al. (2009), "Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma", Cancer Letter Journal, 286, pp. 80-88.

170. Pybus, O. & al. (2009), "Genetic History of Hepatitis C Virus in East Asia", J. Virol., 83(2), pp. 1071-1082.

171. Quan, V. M., Go, V. F. & al. (2009), "Risk for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: A case-control study", AIDS Care Journal, 21(1), pp. 7-16.

172. Ramia, S. & Eid-Fares, J. (2006), "Distribution of hepatitis c virus genotypes in the Middle East", Intern. Infect. Dis. Journal, 10, pp. 272- 277.

173. Reddy, G. A. & al. (2005), "Prevalence og HBV and HCV dual infection in patients on haemodialysis", Indian Med. Microbiol. Journal, 23 (1), pp. 41-43.

174. Rein, D. B. & al. (2012), "The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings", Annals of Internal Med. Journal, 156(4), pp. 263-271.

175. Requejo, H. I. Z. (2006), "Wolrwide Molecular epidemiology of HIV",

Rev. Saude. Publica. J., 40 (2), pp. 331-45.

176. Rezvan, H., Abolghassemi, H. & al. (2007), "Trasfusion-transmitted infections among multitransfused patients in Iran: a review", Transfusion Medicine Journal, 17, pp. 425-433.

177. Rich, J. D., Lynn, E. & Taylor, L. E. (2010), "The Beginning of a New Era in Understanding Hepatitis C Virus Prevention", IInfect. Dis. Journal, 202(7), pp. 981-983.

178. Robotin, M. C. (2011), "Hepatitis B prevention and control: Lessons from the East and the West", World Hepatol. Journal, Vol. 3(2), pp. 31-37.

179. Rockstroh, J. K., Bhagani, S. & Benhamou, Y. (2008), "European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults", HIV Medicine J., 9, pp. 82-88.

180. Ruan, Y. & al. (2009), "Risk Factors for Syphilis and Prevalence of HIV, Hepatitis B and C among Men Who Have Sex with Men in Beijing, China: Implications for HIV prevention", AIDS Behav. J., 13 (4), pp. 663-670.

181. Saha, D. & Agarwal, S. K. (2001), "Hepatitis and HIV infection During Haemodialysis", Indian Med. Assoc. Journal, 99(4), pp. 194-199.

182. Saksena, N. K., Wang, B. & al. (2005), "Snapshot of HIV pathogenesis in China", Cell. Res. Journal, 15, pp. 953-61.

183. Scott, J. D. & Gretch, D. R. (2007), "Molercular Diagnostics of Hepatitis C Virus Infection: A Systematic Review", JAMA Journal, 297(7), pp. 724-732.

184. Scotto, G., Martinalli, D. & Tullio, R. D. (2010), "Epidemiological and Clinical Features of Hepatitis B Virus Genotypes among